A case of disseminated cryptococcal disease after Bruton tyrosine kinase inhibitor therapy: A brief review in the Australian context
Nicholas Van Rooij, MD,
Jesse Johnston, MBBS, FACD,
Rohan Mortimore, MBBS, FRCPA,
Ivan Robertson, MBBS, FACD
Affiliations
Nicholas Van Rooij, MD
The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; School of Medicine, Griffith University, Southport, Queensland, Australia; Faculty of Medicine, The University of Queensland, St Lucia, Queensland, Australia; Correspondence to: Nicholas Van Rooij, MD, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4006, Australia.
Jesse Johnston, MBBS, FACD
The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
Rohan Mortimore, MBBS, FRCPA
The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
Ivan Robertson, MBBS, FACD
The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia